glp 1 effect on liver Weight loss with GLP-1 medicines does not result in a disproportionate loss of muscle mass or function in obese mice and humans GLP-1 receptor agonists show promise

Malhotra V., Sakhuja P., Gondal R

In this GLP-1 round up: One of the clearest themes to emerge from Februarys research is a reinforcement of something the evidence has been pointing to for years: GLP-1 therapy works best and lasts longest when it is delivered as part of a comprehensive, chronic-disease care model rather than as a standalone prescription

Tier 1: recommended for regular use Polyethylene glycol (MiraLAX)

It was developed by Novo Nordisk in the mid-1990s as part of a research program investigating selective growth hormone secretagogues

Not all sources are safemake sure to verify pharmacy credentials